6351 - 6360 of 8620 Results
Title
Year
-
OPENTitle: Impact of increased APP gene dose in Down syndrome and the Dp16 mouse modelJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 6Start Page: 1203End Page: 1234Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12463Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9085977Citation Count: 44
- Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tau2021OPENTitle: Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tauJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.050391Citation Count: 0
- MRI biomarkers of small vessel disease and cognition: A cross‐sectional study of a cognitively normal Mexican American cohort2021OPENTitle: MRI biomarkers of small vessel disease and cognition: A cross‐sectional study of a cognitively normal Mexican American cohortJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/dad2.12236Best OA location URL: https://escholarship.org/content/qt96q1x4rv/qt96q1x4rv.pdfCitation Count: 6
-
RESTRICTEDTitle: The Isolation and Deep Sequencing of Mitochondrial DNAJournal Name: Methods in Molecular BiologyPublisher: Springer USVol:Issue #:Start Page: 433End Page: 447Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-1-0716-1270-5_27Citation Count: 6
-
OPENTitle: R869C mutation in molecular motor KIF17 gene is involved in dementia with Lewy bodiesJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/dad2.12143Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/dad2.12143Citation Count: 4
- Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s Disease2021OPENTitle: Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s DiseaseJournal Name: Journal of Health Economics and Outcomes ResearchPublisher: The Journal of Health Economics and Outcomes ResearchVol: 8Issue #: 1Start Page: 99End Page: 105Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.36469/jheor.2021.24620Best OA location URL: https://jheor.org/article/24620.pdfCitation Count: 1
- Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s Disease2021OPENTitle: Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s DiseaseJournal Name: Journal of Health Economics and Outcomes ResearchPublisher: The Journal of Health Economics and Outcomes ResearchVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.36469/001c.24620Best OA location URL: https://doi.org/10.36469/001c.24620Citation Count: 6
- Parkinson’s Kinetigraph in the Selection of Levodopa-Carbidopa Intestinal Gel for Motor Fluctuations Refractory to Deep Brain Stimulation2021OPENTitle: Parkinson’s Kinetigraph in the Selection of Levodopa-Carbidopa Intestinal Gel for Motor Fluctuations Refractory to Deep Brain StimulationJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 14Issue #: 3Start Page: 239End Page: 241Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.20090Best OA location URL: https://doi.org/10.14802/jmd.20090Citation Count: 2
- Development, Efficacy and Safety of Once-daily, Bedtime, Extended-release Amantadine (Gocovri®) to Treat Dyskinesia and OFF Time in Parkinson’s Disease2021OPENTitle: Development, Efficacy and Safety of Once-daily, Bedtime, Extended-release Amantadine (Gocovri®) to Treat Dyskinesia and OFF Time in Parkinson’s DiseaseJournal Name: NeurologyPublisher: Touch Medical Media, Ltd.Vol: 17Issue #: 1Start Page: 36End Page: 36Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.17925/usn.2021.17.1.36Best OA location URL: https://touchneurology.com/wp-content/uploads/sites/3/2021/07/touchNEURO_17.1_pp36-47.pdfCitation Count: 1
- Phenotypic Features of Isolated Essential Tremor, Essential Tremor Plus, and Essential Tremor-Parkinson’s Disease in a Movement Disorders Clinic2021OPENTitle: Phenotypic Features of Isolated Essential Tremor, Essential Tremor Plus, and Essential Tremor-Parkinson’s Disease in a Movement Disorders ClinicJournal Name: Tremor and Other Hyperkinetic MovementsPublisher: Ubiquity Press, Ltd.Vol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.5334/tohm.581Best OA location URL: http://tremorjournal.org/articles/10.5334/tohm.581/galley/1510/download/Citation Count: 38